Dr. Lye Whye Kei
Dr. Lye is the Director of Business Development (Future Health Care) at the Nanyang Technological University in Singapore. He is also the CEO of SysteMED Private Limited, a medical technology accelerator wholly owned by NTU, and is a partner at Nairos LLC, a medtech consulting firm. Prior to Nairos, Dr. Lye was CTO-founder of Setagon, Inc., a startup which developed several proprietary stent technologies, including a metallic nanoporous surface modification for medical devices such as coronary stents. Setagon obtained over US$5.5 million in venture financing and was acquired by Medtronic.
Dr. Lye is the primary inventor of the acquired technology and has over 28 patents/patent applications. His technical experience includes work in the fields of nanoscale materials, micro-electromechanical systems, and biological nanosystems. He has a B.Sc. (Honors) from the California Institute of Technology, and a PhD from Yale University.